European Hospitals to Trial Strategy for Most Common Childhood Brain Tumor

European hospitals are set to test a new treatment strategy for diffuse intrinsic pontine glioma (DIPG), the most common pediatric brain tumor, which is inoperable due to its brainstem location. The trial's design and endpoints are not detailed, but it marks a coordinated European effort against a disease with poor prognosis. Success could shift standard-of-care, though efficacy remains unproven.